Healthcare professionals should approach disclosures of combined peptide use with a non-judgemental but clinically thorough assessment, and provide harm-minimisation advice where appropriate
PMID: 16912693
Neuropathic Pain: For patients with nerve-based pain, including conditions like peripheral neuropathy or chemotherapy-induced peripheral neuropathy, peptides that target nerve repair pathways show remarkable potential without the dependency risks of opioids
WFI (Water for Injection) Approved for human use Manufactured in the United Arab Emirates by a DHA-licensed compounding pharmacy Optimized pH , suitable for a wide range of peptides, including sensitive compounds such as Tesamorelin Contains 0.9% benzyl alcohol USP as a bacteriostatic preservative Quality tested for endotoxins, sterility, pH, benzyl alcohol content, and heavy metals Common uses: Reconstitution of lyophilized compounds and multi-dose vial preparation Format: Sterile injectable solution Specifications: Sterile solution | Storage: 2-8C Use only as directed by a qualified healthcare professional
We usually test before starting treatment, then after 1-3 months
Red Flags to Avoid Several warning signs suggest a supplier should be avoided